A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 262.20
GOOG 1.299.19
MSFT 146.11
BAC 33.18
FB 189.61

Recently Added

RLLCF 0.01
FLES 0.00
APLE 16.37
BGS 16.29
OXLC 9.45

Gaining Speed

AAPL 262.20
GOOG 1.299.19
MSFT 146.11
BAC 33.18
FB 189.61

Mallinckrodt (MNK) Reports Publication of Results of Phase 1b Clinical Trial of StrataGraft® Regenerative Tissue in Burns

Mallinckrodt plc (NYSE: MNK) today announced publication of results of its Phase 1b clinical trial of StrataGraft®, an investigational regenerative tissue, in Burns, the journal of the International Society for Burn Injuries (ISBI). Study data showed that treatment with a single application of StrataGraft tissue resulted in wound closure by...

Read More




Get Alerted When News Hits On This Stock - FREE!